GHISLAINE MAXWELL ACCT. For the Period 1/1/12 to 1/31/12 Note P indicates position adjusted for Pending Trade Activity. Unrealized GainiLoss is shown as "N A" in cases where we do not have appropriate cost information for all lax lots comprising the position. Please contact your J P Morgan team for additional information. Equity Detail Price Quantity Value Adjusted Tax Cost Unrealized Gain/Loss Est. Annual Inc. Yield Original Cost Accrued Div. US Large Cap Equity APACHE CORP 037411-10-5 APA AT&T INC 00206R-10-2 T 98.88 95.000 9,393.60 11,403.30 (2,009.70) 57.00 14.25 0.61 % 0.00 440.00 BANK OF AMERICA CORP 060505-10-4 BAC 7.13 944.000 6,730.72 10,148.85 (3,418.13) 37.76 0.56% BB & T CORP 054937-10-7 BST 0.00 49.44 CITMIROUP INC NEW 172967-42-4 C 30.72 358.000 10,997.76 14,048.52 (3,050.76) 14.32 0.13% P COGNIZANT TECHNOLOGY SOLUTIONS CORP CIA 192446-10-2 CTSH 71.75 0.00 E I DU PONT DE NEMOURS & CO 263534-104 DO 50.89 224.000 11,399.38 11,537.62 (138.28) 367.36 3.22% E M C CORP MASS 268648-10-2 EMC 25.76 468.000 12,055.68 12,378.64 (322.96) ICROGER CO 23.76 265.000 6,296.40 6,587.16 (290.76) 121.90 1.94% 501044-10-1 KR JP Morgan Page 5 of 50 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00048360 SDNY_GM_00317558 EFTA01521007